{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:01:10Z","timestamp":1790611270434,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002378","name":"Faculty of Veterinary Medicine, Cairo University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113716","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T21:54:15Z","timestamp":1733349255000},"page":"113716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Crosstalk between SIRT1\/Nrf2 signaling and NLRP3 inflammasome\/pyroptosis as a mechanistic approach for the neuroprotective effect of linagliptin in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"145","author":[{"given":"Wessam Z.","family":"Ghaith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa","family":"Wadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed F.","family":"EL-Yamany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.intimp.2024.113716_b0005","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jnc.13750","article-title":"Current and experimental treatments of Parkinson disease: A guide for neuroscientists","volume":"139","author":"Oertel","year":"2016","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.intimp.2024.113716_b0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.intimp.2024.113716_b0015","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3389\/fnins.2018.00693","article-title":"Emerging Treatment Approaches for Parkinson's Disease","volume":"12","author":"Stoker","year":"2018","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.intimp.2024.113716_b0020","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and Treatment of Parkinson Disease: A Review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.intimp.2024.113716_b0025","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"The Lancet. Neurology"},{"issue":"3","key":"10.1016\/j.intimp.2024.113716_b0030","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2024.113716_b0035","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson's disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.intimp.2024.113716_b0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-1-14","article-title":"Microglia and neuroinflammation: a pathological perspective","volume":"1","author":"Streit","year":"2004","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.intimp.2024.113716_b0045","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.intimp.2024.113716_b0050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/emm.2006.40","article-title":"Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease","volume":"38","author":"Kim","year":"2006","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.intimp.2024.113716_b0055","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nri3086","article-title":"Microglial cell origin and phenotypes in health and disease","volume":"11","author":"Saijo","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"7575","key":"10.1016\/j.intimp.2024.113716_b0060","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"issue":"64","key":"10.1016\/j.intimp.2024.113716_b0065","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abj3859","article-title":"NLRP3 inflammasome activation triggers gasdermin D-independent inflammation","volume":"6","author":"Wang","year":"2021","journal-title":"Sci. Immunol."},{"issue":"7610","key":"10.1016\/j.intimp.2024.113716_b0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature18629","article-title":"Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2024.113716_b0075","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/eji.201747404","article-title":"The Gasdermin-D pore acts as a conduit for IL-1\u03b2 secretion in mice","volume":"48","author":"Heilig","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2024.113716_b0080","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/j.1462-5822.2006.00751.x","article-title":"Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages","volume":"8","author":"Fink","year":"2006","journal-title":"Cell. Microbiol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113716_b0085","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s10875-010-9440-3","article-title":"Molecular mechanism of NLRP3 inflammasome activation","volume":"30","author":"Jin","year":"2010","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113716_b0090","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/nyas.12458","article-title":"Mechanism of NLRP3 inflammasome activation","volume":"1319","author":"Sutterwala","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2024.113716_b0095","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41590-023-01526-w","article-title":"Molecular mechanisms of gasdermin D pore-forming activity","volume":"24","author":"Devant","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.113716_b0100","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","article-title":"The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson's disease","volume":"67","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.113716_b0105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2024.113716_b0110","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s11064-017-2185-0","article-title":"The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson's Disease in Rats","volume":"42","author":"Mao","year":"2017","journal-title":"Neurochem. Res."},{"issue":"465","key":"10.1016\/j.intimp.2024.113716_b0115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4066","article-title":"Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice","volume":"10","author":"Gordon","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.intimp.2024.113716_b0120","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1080\/15548627.2019.1596481","article-title":"Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease","volume":"15","author":"Han","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.intimp.2024.113716_b0125","article-title":"Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy","author":"de Ara\u00fajo","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113716_b0130","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s12035-020-02198-5","article-title":"NLRP3 Inflammasome Inhibition Prevents \u03b1-Synuclein Pathology by Relieving Autophagy Dysfunction in Chronic MPTP-Treated NLRP3 Knockout Mice","volume":"58","author":"Ou","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.intimp.2024.113716_b0135","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.cellsig.2013.06.007","article-title":"Antagonistic crosstalk between NF-\u03baB and SIRT1 in the regulation of inflammation and metabolic disorders","volume":"25","author":"Kauppinen","year":"2013","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.intimp.2024.113716_b0140","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2337\/db14-0325","article-title":"ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-1\u03b1\/PPAR-\u03b1 signaling","volume":"64","author":"Khan","year":"2015","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.intimp.2024.113716_b0145","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s13105-016-0492-6","article-title":"The role of sirtuins in cellular homeostasis","volume":"72","author":"Kupis","year":"2016","journal-title":"J. Physiol. Biochem."},{"issue":"5","key":"10.1016\/j.intimp.2024.113716_b0150","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s10072-020-04711-z","article-title":"Reduced serum SIRT1 levels in patients with Parkinson's disease: a cross-sectional study in China","volume":"42","author":"Zhu","year":"2021","journal-title":"Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"8","key":"10.1016\/j.intimp.2024.113716_b0155","article-title":"SIRT1 improves lactate homeostasis in the brain to alleviate parkinsonism via deacetylation and inhibition of PKM2","volume":"5","author":"Lian","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.113716_b0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000328516","article-title":"Resveratrol-activated AMPK\/SIRT1\/autophagy in cellular models of Parkinson's disease","volume":"19","author":"Wu","year":"2011","journal-title":"Neurosignals"},{"issue":"6","key":"10.1016\/j.intimp.2024.113716_b0165","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/ar.23781","article-title":"Resveratrol Suppresses Rotenone-induced Neurotoxicity Through Activation of SIRT1\/Akt1 Signaling Pathway","volume":"301","author":"Wang","year":"2018","journal-title":"Anatomical record (Hoboken, N.J.: 2007)"},{"key":"10.1016\/j.intimp.2024.113716_b0170","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.abb.2019.07.008","article-title":"Dulaglutide inhibits high glucose- induced endothelial dysfunction and NLRP3 inflammasome activation","volume":"671","author":"Luo","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.intimp.2024.113716_b0175","article-title":"Metformin Alleviates LPS-Induced Acute Lung Injury by Regulating the SIRT1\/NF-\u03baB\/NLRP3 Pathway and Inhibiting Endothelial Cell Pyroptosis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113716_b0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0197-4580(94)90143-0","article-title":"Neuron loss and shrinkage in the amygdala in Alzheimer's disease","volume":"15","author":"Vereecken","year":"1994","journal-title":"Neurobiol. Aging"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.113716_b0185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11064-016-1844-x","article-title":"Autophagy in Neurodegenerative Diseases and Metal Neurotoxicity","volume":"41","author":"Zhang","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.intimp.2024.113716_b0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tox.2017.12.006","article-title":"Cadmium induced ROS alters M1 and M3 receptors, leading to SN56 cholinergic neuronal loss, through AChE variants disruption","volume":"394","author":"Moyano","year":"2018","journal-title":"Toxicology"},{"issue":"7","key":"10.1016\/j.intimp.2024.113716_b0195","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/cns.12404","article-title":"DPP-4 Inhibitor Linagliptin Attenuates A\u03b2-induced Cytotoxicity through Activation of AMPK in Neuronal Cells","volume":"21","author":"Kornelius","year":"2015","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.intimp.2024.113716_b0200","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12933-015-0218-z","article-title":"DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice","volume":"14","author":"Ma","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113716_b0205","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/ijp.IJP_384_20","article-title":"Neuroprotective effects of linagliptin in a rotenone-induced rat model of Parkinson's disease","volume":"54","author":"Abhangi","year":"2022","journal-title":"Indian Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.intimp.2024.113716_b0210","doi-asserted-by":"crossref","first-page":"242","DOI":"10.18621\/eurj.1010322","article-title":"Beneficial effects of linagliptin in cell culture model of parkinson\u2019s disease","volume":"8","author":"Okkay","year":"2022","journal-title":"The European Research Journal"},{"key":"10.1016\/j.intimp.2024.113716_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175498","article-title":"Linagliptin counteracts rotenone's toxicity in non-diabetic rat model of Parkinson's disease: Insights into the neuroprotective roles of DJ-1, SIRT-1\/Nrf-2 and implications of HIF1-\u03b1","volume":"941","author":"ElGamal","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2024.113716_b0220","first-page":"1818","article-title":"Exendin-4 and linagliptin attenuate neuroinflammation in a mouse model of Parkinson's disease","volume":"18","author":"Yu","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.intimp.2024.113716_b0225","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/1673-5374.177724","article-title":"The neuroprotective effects of the anti-diabetic drug linagliptin against A\u03b2-induced neurotoxicity","volume":"11","author":"Lin","year":"2016","journal-title":"Neural Regen. Res."},{"issue":"8","key":"10.1016\/j.intimp.2024.113716_b0230","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3390\/ph16081065","article-title":"Neuroprotective Impact of Linagliptin against Cadmium-Induced Cognitive Impairment and Neuropathological Aberrations: Targeting SIRT1\/Nrf2 Axis, Apoptosis, and Autophagy","volume":"16","author":"Arab","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.intimp.2024.113716_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104765","article-title":"Comparative pharmacodynamic study delineating the efficacy of amantadine loaded nano-emulsified organogel via intranasal versus transdermal route in rotenone-induced Parkinson's disease rat model","volume":"86","author":"Farag","year":"2023","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"16","key":"10.1016\/j.intimp.2024.113716_b0240","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.3390\/ijms20164052","article-title":"Neuroprotective Properties of Linagliptin: Focus on Biochemical Mechanisms in Cerebral Ischemia, Vascular Dysfunction and Certain Neurodegenerative Diseases","volume":"20","author":"Wici\u0144ski","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2024.113716_b0245","first-page":"254","article-title":"Review of Intraperitoneal Injection of Sodium Pentobarbital as a Method of Euthanasia in Laboratory Rodents","volume":"59","author":"Laferriere","year":"2020","journal-title":"Journal of the American Association for Laboratory Animal Science: JAALAS"},{"issue":"6","key":"10.1016\/j.intimp.2024.113716_b0250","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1007\/s10753-019-01068-0","article-title":"Potential Anti-Inflammatory Effect of Escitalopram in Iodoacetamide-Induced Colitis in Depressed Ovariectomized Rats: Role of \u03b17-nAChR","volume":"42","author":"Abdo","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2024.113716_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.731483","article-title":"Liraglutide Improves Cognitive and Neuronal Function in 3-NP Rat Model of Huntington's Disease","volume":"12","author":"Shawki","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113716_b0260","article-title":"Modulation of endoplasmic reticulum stress response in gut-origin encephalopathy: Impact of vascular endothelial growth factor receptor-2 manipulation","volume":"117654","author":"Zaky","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2024.113716_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.114386","article-title":"Rice bran extract mitigates depressive-like behavior in dextran sulfate sodium-induced colitis: Involvement of the gut-brain axis and Sirt1 signaling pathway","volume":"184","author":"Shendy","year":"2024","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.intimp.2024.113716_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122004","article-title":"Niacin modulates depressive-like behavior in experimental colitis through GPR109A-dependent mechanisms","volume":"330","author":"Wadie","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2024.113716_b0275","series-title":"Handbook of histopathological and histochemical techniques: Including museum techniques","author":"Culling","year":"2013"},{"issue":"11","key":"10.1016\/j.intimp.2024.113716_b0280","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00384-012-1473-z","article-title":"STW 5 is effective in dextran sulfate sodium-induced colitis in rats","volume":"27","author":"Wadie","year":"2012","journal-title":"Int. J. Colorectal Dis."},{"issue":"6","key":"10.1016\/j.intimp.2024.113716_b0285","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00210-018-1491-7","article-title":"Sodium selenite ameliorates both intestinal and extra-intestinal changes in acetic acid-induced colitis in rats","volume":"391","author":"Soliman","year":"2018","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"10.1016\/j.intimp.2024.113716_b0290","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.taap.2018.05.035","article-title":"Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: A pivotal role of AMPK\/SIRT1 and JAK2\/STAT3\/NF-\u03baB signalling pathway modulation","volume":"352","author":"Elbaz","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113716_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105014","article-title":"Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson's disease: The therapeutic role of Nrf2 activators","volume":"145","author":"Jayaram","year":"2021","journal-title":"Neurochem. Int."},{"issue":"7","key":"10.1016\/j.intimp.2024.113716_b0300","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/ijms20071538","article-title":"Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson's Disease","volume":"20","author":"Javed","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.113716_b0305","article-title":"Baicalein Exerts Anti-Neuroinflammatory Effects by Inhibiting the TLR4-ROS \/NF-\u03baB-NLRP3 Inflammasome","volume":"16","author":"Xin","year":"2021","journal-title":"Nat. Prod. Commun."},{"issue":"6","key":"10.1016\/j.intimp.2024.113716_b0310","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.3390\/ijms24065222","article-title":"Limonene, a Monoterpene, Mitigates Rotenone-Induced Dopaminergic Neurodegeneration by Modulating Neuroinflammation, Hippo Signaling and Apoptosis in Rats","volume":"24","author":"Eddin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2024.113716_b0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228750","article-title":"The dipeptidyl peptidase-4 inhibitor, linagliptin, improves cognitive impairment in streptozotocin-induced diabetic mice by inhibiting oxidative stress and microglial activation","volume":"15","author":"Ide","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.intimp.2024.113716_b0320","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s12264-019-00446-w","article-title":"DPP-4 Inhibitor Linagliptin is Neuroprotective in Hyperglycemic Mice with Stroke via the AKT\/mTOR Pathway and Anti-apoptotic Effects","volume":"36","author":"Zhang","year":"2020","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.intimp.2024.113716_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.05.043","article-title":"DL-3-n-butylphthalide attenuates lipopolysaccharide-induced acute lung injury via SIRT1-dependent and -independent regulation of Nrf2","volume":"74","author":"Gong","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2024.113716_b0330","article-title":"SIRT1-dependent mitochondrial biogenesis supports therapeutic effects of vidarabine against rotenone-induced neural cell injury","volume":"9","author":"Li","year":"2023","journal-title":"Heliyon"},{"issue":"11","key":"10.1016\/j.intimp.2024.113716_b0335","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3390\/biology10111219","article-title":"Terretonin as a New Protective Agent against Sepsis-Induced Acute Lung Injury: Impact on SIRT1\/Nrf2\/NF-\u03baBp65\/NLRP3 Signaling","volume":"10","author":"Mohamed","year":"2021","journal-title":"Biology"},{"issue":"2","key":"10.1016\/j.intimp.2024.113716_b0340","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1471-4159.2012.07769.x","article-title":"Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease","volume":"122","author":"Xie","year":"2012","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.intimp.2024.113716_b0345","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","article-title":"MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration","volume":"26","author":"Lee","year":"2019","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.intimp.2024.113716_b0350","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12974-019-1670-6","article-title":"Systemic activation of NLRP3 inflammasome and plasma \u03b1-synuclein levels are correlated with motor severity and progression in Parkinson's disease","volume":"17","author":"Fan","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2024.113716_b0355","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.bbi.2020.10.010","article-title":"Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson's disease","volume":"91","author":"Qin","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2024.113716_b0360","article-title":"Targeting Microglial \u03b1-Synuclein\/TLRs\/NF-kappaB\/NLRP3 Inflammasome Axis in Parkinson's Disease","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2024.113716_b0365","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/cr.2016.100","article-title":"Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis","volume":"26","author":"Chen","year":"2016","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.intimp.2024.113716_b0370","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1159\/000489365","article-title":"Salidroside Protection Against Oxidative Stress Injury Through the Wnt\/\u03b2-Catenin Signaling Pathway in Rats with Parkinson's Disease","volume":"46","author":"Wu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2024.113716_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2020.104274","article-title":"Neuroprotective effects of natural cordycepin on LPS-induced Parkinson\u2019s disease through suppressing TLR4\/NF-\u03baB\/NLRP3-mediated pyroptosis","volume":"75","author":"Sun","year":"2020","journal-title":"Journal of functional foods"},{"issue":"9","key":"10.1016\/j.intimp.2024.113716_b0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045186","article-title":"Distinct licensing of IL-18 and IL-1\u03b2 secretion in response to NLRP3 inflammasome activation","volume":"7","author":"Schmidt","year":"2012","journal-title":"PLoS One"},{"issue":"2\u20133","key":"10.1016\/j.intimp.2024.113716_b0385","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000511207","article-title":"Suppression of NLRP3 Inflammasome, Pyroptosis, and Cell Death by NIM811 in Rotenone-Exposed Cells as an in vitro Model of Parkinson's Disease","volume":"20","author":"Zhang","year":"2020","journal-title":"Neurodegener Dis"},{"issue":"10","key":"10.1016\/j.intimp.2024.113716_b0390","doi-asserted-by":"crossref","first-page":"9405","DOI":"10.18632\/aging.103215","article-title":"Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging"},{"issue":"15","key":"10.1016\/j.intimp.2024.113716_b0395","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202106723","article-title":"Prussian Blue Nanozyme as a Pyroptosis Inhibitor Alleviates Neurodegeneration","volume":"34","author":"Ma","year":"2022","journal-title":"Advanced Materials (Deerfield Beach, Fla.)"},{"issue":"Pt B","key":"10.1016\/j.intimp.2024.113716_b0655","article-title":"Recombinant human growth hormone improves the immune status of rats with septic encephalopathy: The role of VEGFR2 in the prevalence of endoplasmic reticulum stress repair module","volume":"101","author":"Zaky","year":"2021","journal-title":"Int. Immunopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924022380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924022380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T19:41:06Z","timestamp":1734637266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924022380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":80,"alternative-id":["S1567576924022380"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113716","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crosstalk between SIRT1\/Nrf2 signaling and NLRP3 inflammasome\/pyroptosis as a mechanistic approach for the neuroprotective effect of linagliptin in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113716"}}